rs55722856

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_000531.6(OTC):​c.718-14T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0105 in 1,208,527 control chromosomes in the GnomAD database, including 879 homozygotes. There are 3,338 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.054 ( 461 hom., 1564 hem., cov: 22)
Exomes 𝑓: 0.0061 ( 418 hom. 1774 hem. )

Consequence

OTC
NM_000531.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.512

Publications

3 publications found
Variant links:
Genes affected
OTC (HGNC:8512): (ornithine transcarbamylase) This nuclear gene encodes a mitochondrial matrix enzyme. The encoded protein is involved in the urea cycle which functions to detoxify ammonia into urea for excretion. Mutations in this enzyme lead to ornithine transcarbamylase deficiency, which causes hyperammonemia. [provided by RefSeq, May 2022]
OTC Gene-Disease associations (from GenCC):
  • ornithine carbamoyltransferase deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Laboratory for Molecular Medicine, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant X-38408862-T-C is Benign according to our data. Variant chrX-38408862-T-C is described in ClinVar as Benign. ClinVar VariationId is 93223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.185 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTCNM_000531.6 linkc.718-14T>C intron_variant Intron 7 of 9 ENST00000039007.5 NP_000522.3 P00480
OTCNM_001407092.1 linkc.718-14T>C intron_variant Intron 9 of 11 NP_001394021.1
OTCXM_017029556.2 linkc.718-14T>C intron_variant Intron 7 of 8 XP_016885045.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTCENST00000039007.5 linkc.718-14T>C intron_variant Intron 7 of 9 1 NM_000531.6 ENSP00000039007.4 P00480
ENSG00000250349ENST00000465127.1 linkc.172-257259T>C intron_variant Intron 3 of 8 5 ENSP00000417050.1 B4E171

Frequencies

GnomAD3 genomes
AF:
0.0541
AC:
6011
AN:
111052
Hom.:
461
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.189
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0170
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00844
Gnomad SAS
AF:
0.000766
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000528
Gnomad OTH
AF:
0.0301
GnomAD2 exomes
AF:
0.0168
AC:
3081
AN:
183273
AF XY:
0.0107
show subpopulations
Gnomad AFR exome
AF:
0.197
Gnomad AMR exome
AF:
0.00974
Gnomad ASJ exome
AF:
0.000134
Gnomad EAS exome
AF:
0.00888
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000379
Gnomad OTH exome
AF:
0.00796
GnomAD4 exome
AF:
0.00607
AC:
6663
AN:
1097423
Hom.:
418
Cov.:
30
AF XY:
0.00489
AC XY:
1774
AN XY:
362805
show subpopulations
African (AFR)
AF:
0.195
AC:
5157
AN:
26385
American (AMR)
AF:
0.0103
AC:
364
AN:
35204
Ashkenazi Jewish (ASJ)
AF:
0.0000516
AC:
1
AN:
19378
East Asian (EAS)
AF:
0.00394
AC:
119
AN:
30194
South Asian (SAS)
AF:
0.00187
AC:
101
AN:
54132
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40533
Middle Eastern (MID)
AF:
0.00459
AC:
19
AN:
4135
European-Non Finnish (NFE)
AF:
0.000240
AC:
202
AN:
841388
Other (OTH)
AF:
0.0152
AC:
700
AN:
46074
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
254
507
761
1014
1268
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
166
332
498
664
830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0543
AC:
6034
AN:
111104
Hom.:
461
Cov.:
22
AF XY:
0.0469
AC XY:
1564
AN XY:
33328
show subpopulations
African (AFR)
AF:
0.189
AC:
5752
AN:
30402
American (AMR)
AF:
0.0169
AC:
176
AN:
10444
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2643
East Asian (EAS)
AF:
0.00847
AC:
30
AN:
3541
South Asian (SAS)
AF:
0.000769
AC:
2
AN:
2602
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6004
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.000528
AC:
28
AN:
53051
Other (OTH)
AF:
0.0304
AC:
46
AN:
1513
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
182
364
545
727
909
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0447
Hom.:
582
Bravo
AF:
0.0639

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Ornithine carbamoyltransferase deficiency Benign:4
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Apr 12, 2019
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 28, 2022
Color Diagnostics, LLC DBA Color Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Jun 10, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
2.4
DANN
Benign
0.52
PhyloP100
-0.51
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.25
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.25
Position offset: 14

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55722856; hg19: chrX-38268115; API